Bill > SB1022

This bill updates Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act to expand provisions related to emergency opioid antagonists (such as naloxone) and provide more comprehensive guidelines for their use and distribution. The bill introduces new definitions for terms like "opioid," "emergency opioid antagonist," and "coprescribe," and mandates that healthcare professionals prescribing opioids must also coprescribe an emergency opioid antagonist. The legislation requires various institutions, including public and nonpublic schools, correctional institutions, and institutions of higher education, to maintain supplies of emergency opioid antagonists and provide training on their use. The bill also establishes protections for healthcare professionals, first responders, and other individuals who administer emergency opioid antagonists in good faith, shielding them from criminal and civil liability. Additionally, the bill requires the development of model training programs that cover topics such as recognizing overdose symptoms, administering antagonists, understanding state laws, and reducing stigma surrounding opioid overdose interventions. Correctional institutions are specifically required to offer emergency opioid antagonists to individuals upon release and provide instructions on their use, aiming to reduce overdose risks among recently released individuals.

Health and Social Services

https://www.palegis.us/legislation/bills/2025/sb1022